Vimarsana
Biggest News Aggregation in the World

Page 47 - Et Cest News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Et Cest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Et Cest Today - Breaking & Trending Today

EQS-News: Steinhoff International Holdings N.V. : DATE CONFIRMATION HEARING - Vimarsana News

EQS-News: Steinhoff International Holdings N.V. : DATE CONFIRMATION HEARING

EQS-News: Steinhoff International Holdings N.V. / Key word(s): Miscellaneous Steinhoff International Holdings N.V. : DATE CONFIRMATION HEARING 02.06.2023 / 17:10 CET/CEST The issuer is solely responsible for the content of this announcement.   STEINHOFF INTERNATIONAL HOLDINGS N.V. – DATE CONFIRM...

EQS-News: Steinhoff International Holdings N.V. : FILING OF REQUEST FOR CONFIRMATION, PUBLICATION OF VOTING REPORT AND AVAILIBILITY OF REQUEST FOR CONFIRMATION - Vimarsana News

EQS-News: Steinhoff International Holdings N.V. : FILING OF REQUEST FOR CONFIRMATION, PUBLICATION OF VOTING REPORT AND AVAILIBILITY OF REQUEST FOR CONFIRMATION

EQS-News: Steinhoff International Holdings N.V. / Key word(s): Miscellaneous Steinhoff International Holdings N.V. : FILING OF REQUEST FOR CONFIRMATION, PUBLICATION OF VOTING REPORT AND AVAILIBILITY OF REQUEST FOR CONFIRMATION 01.06.2023 / 08:30 CET/CEST The issuer is solely responsible for the ...

EQS-News: Skyborn Renewables appoints Stine Würtz Jepsen as CHRO - Vimarsana News

EQS-News: Skyborn Renewables appoints Stine Würtz Jepsen as CHRO

Issuer: Skyborn Renewables GmbH / Key word(s): Personnel Skyborn Renewables appoints Stine Würtz Jepsen as CHRO 01.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Hamburg, Germany, June 1, 2023 Skyborn Renewables (Skyborn) has appointed Stine Würtz...

EQS-News: Apogenix AG: Apogenix' new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model - Vimarsana News

EQS-News: Apogenix AG: Apogenix' new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model

EQS-News: Apogenix AG / Key word(s): Scientific publication Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model 01.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Apogenix’ new CD40 agonist...

EQS-NVR: BP p.l.c.: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Vimarsana News

EQS-NVR: BP p.l.c.: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Total Voting Rights Announcement: BP p.l.c. / Total Voting Rights Announcement BP p.l.c.: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 01.06.2023 / 10:00 CET/CEST Total Voting Rights Announcement transmitted by...